drugset / Trial / NCT00795821
A Study in Adult Patients With Major Depressive Disorder
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess whether LY2216684 is superior to placebo in the treatment of adult patients with major depressive disorder.
Timeline
- Start
- 2008-12
- Primary completion
- 2010-02
- Completion
- 2011-03
Outcome
Met primary endpoint
registry analysis (superiority or other test); LY2216684 vs Placebo; p <0.001; Mixed Models Analysis NCT00795821 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | edivoxetine | Small molecule | 6 mg | — |
| Subject | edivoxetine | Small molecule | 9 mg | — |
| Subject | edivoxetine | Small molecule | 12 mg | — |
| Subject | edivoxetine | Small molecule | 18 mg | — |